NCT00211653View on ClinicalTrials.gov

Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

November 30, 2006

Conditions
Kidney Failure
Interventions
DRUG

N-Acetylcysteine

Trial Locations (1)

55417

Veterans Affairs Medical Center, Minneapolis

All Listed Sponsors
lead

Minneapolis Veterans Affairs Medical Center

FED

NCT00211653 - Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery | Biotech Hunter | Biotech Hunter